Tissue-protective properties of erythropoietin (EPO) have let to the discovery of an alternative EPO signaling via an EPO-R/CD131 receptor complex which can now be specifically targeted through pharmaceutically designed short sequence peptides such as ARA290. However, little is still known about specific functions of alternative EPO signaling in defined cell populations. In this study, we investigated effects of signaling through EPO-R/CD131 complex on cellular stress responses and pro-inflammatory activation in different mesenchymalderived phenotypes. We show that anti-apoptotic, antiinflammatory effects of ARA290 and EPO coincide with the externalization of CD131 receptor component as an immediate response to cellular stress. In addition, alternative EPO signaling strongly modulated transcriptional, translational, or metabolic responses after stressor removal. Specifically, we saw that ARA290 was able to overcome a TNFα-mediated inhibition of transcription factor activation related to cell stress responses, most notably of serum response factor (SRF), heat shock transcription factor protein 1 (HSF1), and activator protein 1 (AP1). We conclude that alternative EPO signaling acts as a modulator of pro-inflammatory signaling pathways and likely plays a role in restoring tissue homeostasis.
Introduction At a local, nonsystemic level, various tissues have demonstrated the ability to secrete erythropoietin (EPO) and express the EPO receptor (EPO-R) under conditions of stress, likely as part of a paracrine/autocrine local tissue-protective mechanism [1] . When systemically administered at supraphysiological levels, EPO is tissue-protective in various injury models [2] . Immunoprecipitation experiments revealed a colocalization of EPO-R with the common-beta-chain-receptorsubunit-beta 2 (CSF2RB) [3] , also referred to as CD131. A growing body of evidence suggests that EPO-R/CD131 complex-mediated signaling is responsible for observed tissueprotective effects of various EPO derivatives [4] . Notably, in a CD131 knockout mouse, EPO is devoid of tissue-protective properties but demonstrates normal hematopoiesis [5] .
In order to study the specific effects of signaling via the EPO-R/CD131 complex on cellular stress responses, we used the pharmaceutically designed 11 amino-acid helix beta surface peptide, referred to as ARA290 [4] . This peptide selectively binds, with high affinity, to the EPO-R/CD131 receptor heterodimer complex but not to classic EPO-R/EPO-R homodimer. Thus, clinically relevant side effects related to high-dose EPO administration can be avoided [6] . In vivo, we and others have already shown the effectiveness of ARA290 in the nanomolar range to reduce tissue damage [7] . In the present study, we investigated CD131 expression profiles as well as the effects of EPO-R/CD131-mediated signaling on cellular stress responses in vitro. Our findings show that EPO-R/CD131-mediated signaling dampens pro-inflammatory and pro-apoptotic pathways. This was observed in different cell lines of mesenchymal origin, suggesting that this mechanism plays an important role in restoring homeostasis following tissue injury.
Materials and methods
Animals Primary cell lines were isolated from male C57BL/6 adult wild-type mice (>6 weeks, >20 g) purchased from The Jackson Laboratory (ME; www.jax.org). All animal procedures were performed in accordance with the National Research Council guidelines and were approved by the Subcommittee on Research Animal Care at Massachusetts General Hospital, Boston, MA.
Cell isolations and culture Primary mouse fibroblastic cell lines were isolated as previously described [8] . Phenotypic uniform cultures between passages 3 and 10 from skin/ adipose (mSFBs) or aortic (mAFBs) tissue of male C57BL/6 wild-type mice as well as the mouse macrophage cell line J774A.1 (mJ774s) were maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco™, USA) supplemented with 10 % heat-inactivated fetal bovine serum (hiFBS), L-glutamine (200 mM), and penicillin (10,000 U/l)/streptomycin (10 mg/ml) (P/S). Human microvascular endothelial cells (hMECs) (Lot#: 7F3109, Lonza™, CH) were maintained using MCDB 131 medium (Caisson Laboratories™, USA) supplemented with 10 % hiFBS, P/S, hydrocortisone (1 μg/ml), dibutyryl cAMP (80 μM), heparin (2 U/ml), endothelial growth cell supplement (25 μg/ml) (EGCS, Biomedical Technologies™, USA), and ascorbic acid (0.2 mM). Mouse bone-marrow-derived mesenchymal stem cells (mBMSCs, GIBCO® Mouse C57BL/six mesenchymal stem cells, Invitrogen™, USA) were maintained in MEM-α basal media supplemented with fibroblast growth factor 2 (both Invitrogen™, USA) and 10 % hiFBS. Unless mentioned otherwise, cultures were switched to DMEM supplemented with 2 % hiFBS, L-glutamine and 1 μM sodium pyruvate 24 h prior to and following heat shock exposure. For heat shock experiments, cell lines were grown to confluence on fibronectin-coated 10-mm Ø glass cover slips (Fisherbrand™, USA). Heat shock was administered via immersion in a temperature-controlled 0.9 % saline bath followed by transfer to a 12-well plate format at 37°C/5 % CO 2 during recovery. If not specified otherwise, components were purchased from Sigma Chemical USA.
Flow cytometry Cells were fluorescently labeled in suspension with 1:250 dilutions of anti-mouse phycoerythrin-CD131 or isotype-control antibody (both BD Biosciences™, USA) in phosphate-buffered saline (PBS) supplemented with 0.5 % hiFBS at 4°C for 40 min followed by fixation in 1 % PBS-buffered paraformaldehyde. Intracellular labeling for phosphotyrosine/phosphoserine was performed with the 4G10® Platinum/4A4 Phosphopack (Millipore™, USA) and anti-mouse Alexa Fluor® 488 (Invitrogen™, USA) secondary antibody using a BD Cytofix/Cytoperm® kit (BD Biosciences™, USA) buffer. Sorting of labeled isolates was performed using either a BD FACSCalibur® with CellQuestPro® or a BD SORP FACSAria IIs® platform with BD Diva® operating software (all BD Biosciences™, USA), and data was further analyzed using FlowJo® software (www.flowjo.com).
Dye-based viability, cytotoxicity, and metabolic assays We used a fluorescence-based assay (LIVE/DEAD®, Invitrogen™, USA) in order to distinguish between viable (calcein positive) and nonviable (ethidium positive) cells following treatments. Images were acquired using an inverted microscope equipped with an incubation chamber and fluorescence imaging capabilities (Axiovert, Zeiss™, GER) and analyzed using ImageJ 1.43u (http://rsb.info.nih.gov/ij/). To quantify the amount of lactate dehydrogenase (LDH) released into supernates in response to cell stress, we used a colorimetric LDH activity assay kit (Sigma™, USA). Metabolic reducing activity of resazurin dye (AlamarBlue®, Invitrogen™, USA) was measured as previously described [9] using a Synergy HT® plate reader (BioTek™, USA) at 530/590 nm (ex/em) filter settings.
ELISA-based assays Protein concentrations of cell culture supernates or nuclear extracts were measured using enzyme-linked immunosorbent assay (ELISA) formats: mouse TNFα, mouse IL6 (both BD Pharmingen™, NJ), and NFκB p50 (Panomics/Affymetrix™ Nuclear Extraction & TF ELISA Kit, CA)
Transcription factor activation profiling assay Transcription factors (TFs) bound to genomic DNA were isolated using a nuclear extraction kit (Signosis®, USA). Using an oxidative stress transcription factor activation profiling plate array (Signosis®, USA), isolated TFs were then allowed to bind to promoter site-specific, biotin-labeled probes, followed by a column purification step, hybridization to complementary probes sequences, and colorimetric development in a plate format.
Gene expression analysis RNA was extracted from cell cultures using AllPrep DNA/RNA/Protein Mini Kit® (Qiagen™). Total RNA quality was assessed by spectroscopy (NanoDrop®ND-1000, ThermoScientific™, USA) and micro-fluidic gel analysis (Agilent™ RNA 6000 Nano Chip/Agilent™ 2100 Bioanalyzer, GER) followed by cDNA conversion using the SuperScript™ III Platinum® Two-Step qRT-PCR Kit (Invitrogen™, USA) or an RT 2 First Stand Kit® C-03 (SABiosciences™, USA) together with a Perkin Etus Thermal Cycler 480 (PerkinElmer™, USA). The gene expression patterns were then assessed by quantitative PCR (qPCR) with an RT 2 SYBR® Green/Rox qPCR Master Mix (SABiosciences™, USA) using a Stratagene™ mx3005P instrument (Stratagene™, USA). A melting curve was used to confirm the specificity of each primer pair. Each sample was run in triplicate to exclude outliers. Gene expression was analyzed using the commonly used ΔΔCT method (RT 2 qPCR Primer Assay User Manual, Version 2.17, SABiosciences™) with GAPDH as the normalizer gene. The average gene expression was computed for each experimental condition (n≥3) relative to the control (n≥3). Forward (F) and reverse (R) sequence primers (see supplementary Table 1 ) were designed using Primer3 v. 0.4.0 (http://frodo.wi.mit.edu/primer3/) software based on coding DNA sequences (http://www.ncbi. nlm.nih.gov/nuccore).
Statistics
The results are presented as mean±SD and/or SEM. Pairwise comparisons were performed by a two-tailed Student's t test. Statistical analysis was performed using Prism®4.0 (GraphPad, La Jolla, CA) software. In all tests, P<0.05 was considered statistically significant.
Results
Profiling of CD131 cell surface expression First, we used flow cytometry to evaluate CD131 cell surface expression in several cell lines of mesenchymal origin and found CD131 most consistently expressed in primary mouse aortic fibroblasts (mAFBs), mBMSCs [10] or the mouse macrophage cell line J774A.1 (mJ774s) [11] . When cultured under standard conditions, mAFBs exhibited stable CD131+ cell fractions of 20 % for up to ten passages. When stimulated with bacterial lipopolysaccharide (LPS) or exposed to heat shock, CD131+ populations (without observed cell detachment) increased by 2-fold within 2 h (Fig. 1a) . Adding the selective EPO-R/ CD131 ligand ARA290 did not affect CD131 cell surface expression. Similarly, as shown in Fig. 1b , mBMSCs under standard culture conditions showed stable CD131+ cell fractions of~40 %, and stimulation with LPS or TNFα significantly increased this fraction. Also, induction of oxidative stress using tert-butylhydroperoxide (BHP) caused a corresponding dose-dependent increase in the number of CD131+ cells, suggesting a balanced response to cellular stress (Fig. 1b) . However, co-stimulation with ARA290, LPS, or TNFα did not appear to alter this response. Conversely to what we saw in these fibroblastic cell lineages, mJ774s, which also robustly express CD131 along with IL3 and GM-CSF receptor [12] , showed decreased CD131+ cell fractions following stimulation with ARA290, LPS, or BHP (Fig. 1c) . Thus, CD131 expression increased in fibroblasts but decreased in macrophage-like cells in response to cellular stress and/or a pro-inflammatory environment. This in turn indicates an altered phenotype-specific responsiveness to EPO-R/ CD131 complex-mediated signaling under these conditions. Also, the observed changes of CD131 cell surface expression occurred almost immediately following stimulation and thus cannot be explained by de novo protein synthesis alone. We therefore assumed that in order to induce responsiveness to EPO via EPO-R/CD131 receptor complex shortly following cellular stress, preformed cytosolic CD131 would have to translocate to the cell membrane surface.
Cytoprotective, anti-apoptotic effects of selective EPO-R/ CD131 stimulation Sublethal cellular damage is more likely to trigger a controlled process of self-induced cell death/ apoptosis if repair mechanisms fail within a short time period postinjury. We first studied aspects of EPO-R/CD131-mediated signaling that more likely reflect an immediate modulation of cellular stress responses rather than more delayed changes in transcriptional profiles. A Live/Dead® assay was used to evaluate the effect of ARA290 on recovery of mAFBs after immersion heat shock. We saw a significant reduction in cell death if ARA290 was provided within the first hour of an 8-h recovery phase (Fig. 2a) . In addition, we developed an assay based on confluent human microvascular endothelial cell (hMEC) cultures in order to measure the influence of ARA290 on cytoskeletal-driven cell contraction in response to cell stress. In one experiment, 8-h postheat shock, ARA290, and human recombinant EPO (hrEPO) supplementation maintained significantly higher surface coverage of the cultured endothelium compared to controls. Interestingly, a higher surface coverage with viable endothelial cells was also observed with addition of TNFα, with or without ARA290 (Fig. 2b) . Again, we used mAFBs to evaluate the dose dependence of BHPinduced oxidative stress. Following a recovery phase, we measured LDH activity released into supernates as an index of cytotoxicity. We saw a decreased cytotoxicity if ARA290 was supplemented during recovery, most significantly at a 10-μM BHP concentration (Fig. 2c) . We also investigated the effect of EPO-R/CD131 signaling on the ability of cells to maintain a reducing environment within their cytoplasm in the context of oxidative stress and a pro-inflammatory environment using an assay based on the redox indicator dye resazurin in BMSCs. ARA290 supplemented during a 6-h recovery phase following BHPinduced oxidative stress did not appear to significantly affect mitochondrial oxidation capacity but abrogated the increase induced by LPS and TNFα (Fig. 2d) . Thus, ARA290 appears to prevent a further deterioration of the redox capacity of cells promoted by LPS and TNFα in conditions of oxidative stress.
Modulation of inflammatory secretion profiles in response to cell stress Cells can sense and respond to deleterious changes in their environment in several distinctive ways. Most notably, mesenchymal stem cells used in this study besides their potential to differentiate into various mesenchymal-derived phenotypes [13] have demonstrated an outstanding capacity to respond to and modulate inflammatory environments via various secretion products [14] with a net effect of accelerated recovery and improved functional repair of tissues [15] . One characteristic feature of MSCs in cell culture is constitutively high secretion levels of IL6. We found that both LPS and TNFα inhibited IL6 secretion by mBMSCs, which was further diminished by subsequent ARA290 exposure. Furthermore, ARA290 mitigated IL6 secretion stimulated by BHPinduced oxidative stress. Interestingly, IL6 secretion by mBMSCs was unaffected by ARA290 alone (Fig. 3a) . IL6 (%±SD, n≥6, *P<0.05 vs. control condition): a mAFBs, b mBMSCs, and c mJ774s. PE fluorophore/R-phycoerythrin, SSC-H side scatter-high granularity secretion by primary mAFB cultures was strongly induced by LPS (~100-fold), TNFα (~100-fold), and BHP (~5-fold), while ARA290 strongly inhibited this induction (Fig. 3b) . We also evaluated effects of ARA290 on activated mJ774s and found that following a prestimulation with LPS or BHP for 2 h, ARA290 significantly mitigated TNFα secretion (Fig. 3c) . We conclude that EPO-R/CD131-mediated signaling inhibits the secretion of cytokines with a pro-inflammatory net effect such as IL6 and TNFα.
Modulatory effects on transcriptional stress responses Our findings so far indicated a robust, functional expression of CD131 by cells of mesenchymal background. As already mentioned, mBMSCs, which showed highest CD131- positive fractions in cell culture, possess an extraordinary capacity to modulate inflammatory environments e.g. by various secretion products. We assumed that a more longstanding effect of CD131-mediated signaling following cellular stress and/or within a pro-inflammatory environment would also effect the transcriptional response e.g. of mBMSCs. Thus, we performed gene expression analysis of pathways related to apoptosis, inflammation, oxidative stress, hypoxia, cell cycling, and proliferation. Experimental conditions included a 2-h period of BHP-induced (1 μM) cell stress followed by a recovery phase of 6 h. A stress response was modulated by supplementing recovery media with the following components, alone or in combination (including non-BHP-induced controls): AR290 (2 μM), recombinant mouse EPO (rmEPO) (2 μM), LPS (10 ng/ml), and mouse TNFα (2 ng/ml). In the following, we elaborate on the most significant changes in cell stress responses mediated through alternative EPO signaling (for details see Fig. 4 ). First, in the absence of cell stress, expression of EPO-R/CD131 receptor complex appeared not to be influenced in a relevant way by ARA290 or rmEPO stimulation alone. As a general trend, LPS, TNFα, and BHP predominately induced EPO-R (~5-10-fold) over CD131. Evaluation of pathways related to apoptosis revealed Birc5 (survivin) and Bag1, both inhibitors of caspase activation, to be upregulated (~10-fold) by ARA290 or mrEPO added during recovery following BHP-induced oxidative stress. Also with BHP induction, TNFRsf1a and FasR (TNFRsf6) receptors were strongly induced. However, co-stimulation of LPS/TNFα with ARA290/mrEPO appeared to selectively mitigate FasR induction during recovery. Various regulators of cell cycle progression, most notably P53 and P73, were strongly induced by LPS or TNFα stimulation alone. Conversely, BHP-induced oxidative stress suppressed this induction. In this context, co-stimulation during cell stress recovery with ARA290 and mrEPO appeared to mitigate (>10-fold) the induction of P73. We saw the same trend with several known effectors of P53/P73 including cyclin D3 (Ccnd3), cyclin-dependent kinase inhibitors 1c/2a (Cdkn1c/ 2a), cyclin-dependent kinase 5 (Cdk5), Cullin3 (Cul3) [16] , E2F transcription factors 4 (E2F4) [17] , and growth arrest and DNA-damage-inducible beta protein (Gadd45b) [18] . Similarly, ARA290 and mrEPO also decreased LPS-and TNFα-induced upregulation of genes related to a more general activation of cell growth and reorganization, most notably mitogen-activated protein kinase 1/14 (MAPK1/14) [19] . Among marker genes of increased oxidative stress such as glutathione S-transferase M3 (Gstm3), glutathione peroxidase 1 (Gpx1) or superoxide dismutase 1 (Sod1), or peroxiredoxin 1 (Prdx1), Gstm3 was most responsive to BHP-induced oxidative stress in that it was suppressed (~5-fold) by costimulation of ARA290/mrEPO with LPS/TNFα. Among genes related to protein stabilization or degradation such as heat shock transcription factor protein 1 (HSF1), heat shock proteins 27/90ab (HSP27/90ab), prefoldin subunit 1 (Pfdn1), chaperonin containing TCP1, subunit 2 (Cct2), ubiquitinconjugating enzyme E2 E1 (UbE2E1), or autophagy-related protein 2a (Atg2a), HSP27, and Atg2a were most notably upregulated (~5-100-fold) by LPS, TNFα, and BHP. Here, ARA290/mrEPO co-stimulation appeared to act synergistically. However, ARA290/mrEPO stimulation during recovery Fig. 3 Alternative EPO signaling modulates cytokine secretion profiles. Effects of ARA290 on cytokine secretion measured in supernates compared to standard media culture conditions (=control) with a defined cell stress induction period followed by a recovery period: a IL6 secretion of mBMSCs, b IL6 secretion of mAFBs, and c TNFα secretion of mJ774s (all: n≥6, mean±SD, *P<0.05 vs. control condition) from BHP-induced oxidative stress mitigated HSF1 induction by LPS/TNFα. Thus, as expected, our findings show that effects of ARA290 are largely superimposable with those of native erythropoietin (rmEPO), confirming the relevance of alternative EPO signaling via EPO-R/CD131 complex. Also, the effects appeared to be mostly limited to a modulation of cellular stress responses with or without a pro-inflammatory stimulus induced by LPS and/or TNFα but not under conditions where cellular stress was absent. If added during the recovery phase following BHP-induced oxidative stress, ARA290/mrEPO mitigated LPS/TNFα-induced gene expression. Thus, EPO-R/CD131-mediated signaling appears to act as a negative co-modulator of LPS or TNFα-mediated signaling in the context of cell stress responses.
Modulatory effects on intracellular phosphotyrosine/ phosphoserine levels Phosphorylation of functional residues of various proteins is a highly dynamic event occurring during signal transduction, transcriptional modulation, or the regulation of enzymatic activity and is controlled by kinase and phosphatase activity. Again, we chose mBMSCs based on characteristic high levels of tyrosine phosphorylation and low levels of serine phosphorylation. Using an antiphosphotyrosine/phosphoserine-based assay stimulation with LPS or TNFα resulted in decreased levels of phosphorylation in mBMSCs within 20-40 min of exposure. Subsequently, we saw that with tyrosine phosphorylation, ARA290 acted synergistically, with serine phosphorylation antagonistically. This effect was most notable under conditions where LPS/TNFα Fig. 4 Transcriptional profiling of cell stress responses in mBMSCs. Effects of ARA290 and mrEPO on pathway marker genes related to apoptosis, cell cycling, inflammation, hypoxia, oxidative stress, or heat shock in mBMSCs following 2 h of induction with/without LPS, TNFα, or BHP and 6-h recovery with/without ARA290, rmEPO, TNFα, or LPS (shown: qPCR/ΔΔCt method; n=4 pooled samples/condition; fold change color-coded: 0.1>×>10 for respective marker genes (columns) under various stressor conditions (rows) compared to a nonstressed control =1) was removed, followed by a recovery phase of 20 min with or without ARA290 added (Fig. 5a, b) . Effects of ARA290 related to BHP-induced oxidative stress were less consistent, varying greatly with dose and exposure time to BHP. Thus, again we concluded that an important aspect of EPO-R/CD131 complex-mediated signaling is likely to counteract cellular responses induced by a pro-inflammatory environment.
Modulatory effects on transcriptional control
The distinctive changes we saw in the global phosphorylation state of mBMSCs in response to oxidative stress and/or proinflammatory activation suggested a strong, kinase-driven effect on transcriptional regulation. Therefore, we went on to evaluate effects of ARA290 on relative phosphorylation levels of P50 protein (NFκB p50), a major component of nuclear factor kappa-light-chain-enhancer of activated B cell (NFκB) protein complex, using an ELISA-based assay. The NFκB-dependent gene activation is involved in most responses related to cellular stress and inflammation. Well-known activators are not only LPS and TNFα but also reactive oxygen species [20] . We exposed BMSCs to LPS, TNFα, or BHP, followed by a recovery phase with or without ARA290. As expected, we saw a significant increase in NFκB p50 nuclear translocation with all stressors. Although data was inconclusive, ARA290 supplemented to recovery media appeared to inhibit phosphorylation and thus activation of LPS-or TNFα-induced NFκB p50 with a seemingly opposite effect related to BHP-induced oxidative stress. Similarly, in mJ774's LPSinduced NFκB p50, phosphorylation appeared to be mitigated by ARA290 (suppl. Fig. 1 ). In order to further confirm a modulation of various pathways already demonstrated on a transcriptional level (see Fig. 4 ), we continued to profile nuclear translocation of various transcription factors (TFs) related to oxidative stress responses using a DNA hybridization-based assay. A comprehensive summary of those results is given in Fig. 5c . Apart from serum response factor (SRF), which was upregulated over 2-fold, ARA290 did not alter transcription under noncell stress/ noninflammatory conditions. This changed in the case of BHP-induced oxidative stress followed by a recovery phase with treatment with either ARA290 and/or TNFα. ARA290 treatment post-BHP-induced cell stress induced nuclear factor of activated T-cells (NFAT) 3-fold, along with a~1.5-1.8-fold increase in activating transcription factor 4 (ATF4) and hypoxia inducible factor (HIF). Conversely, nuclear translocation of nuclear translocation of activator protein 1 (AP1), corebinding factor (CBF/NFY), early growth response protein 1 (EGR1), E-twenty six TF family (ETS), forkhead box protein O1 (FOXO1), heat shock factor (HSF), interferon regulatory factor TF family (IRF), NFκB, nuclear factor (erythroidderived 2)-like (2NRF2/ARE), P53, and small mothers against decapentaplegic TF family (SMAD) was significantly inhibited. In contrast to ARA290, TNFα essentially inhibited the activation of all evaluated TFs if added during recovery from BHP-induced oxidative stress. Outstanding, however, were effects seen by co-stimulation with both ARA290 and TNFα post-BHP-induced cell stress, showing increased activation of almost all marker TFs, most significantly of SRF (>5-fold), HSF (>2-fold), and AP1 (>2-fold). Intriguingly, signal transducer and activator of transcription 3 (STAT3), which has been associated with classical EPO-R/EPO-R complex-mediated signaling [21] , was least affected. Taken together, our findings suggest that alterative EPO signaling predominately acts as modulator of cellular stress responses with little to no effect during cellular homeostasis.
Discussion
Tissue-protective properties of EPO via the alternative EPO-R/CD131 heteromer receptor complex can be specifically targeted by engineered EPO derivatives such as ARA290 [4] . In this study, we characterized the impact of alternative EPO signaling on stress/inflammatory responses of different cell lines of mesenchymal origin in order to better understand tissue-protective effects previously described in various in vivo models of injury [2] . Also, the particular cell lines were chosen based on their responsiveness to stimulations with the ARA290 peptide which coincided with a high degree of CD131 positive fractions in cell culture. Initially, we confirmed that CD131, which is involved in intracellular signal transduction of IL3/IL5 and GM-CSF receptors [22] , is also expressed on fibroblastic, nonhematopoietic phenotypes. Whereas IL3/5 receptor expression has not been associated with fibroblastic phenotypes, the expression of GM-CSF and its receptor by fibroblasts under co-culture conditions has been reported [22] . However, fibroblasts predominately express fibroblast growth factor (FGF) receptors which share certain characteristics with GM-CSF receptor signaling, including the involvement of heparin/proteoglycans in ligandreceptor binding [23] . Thus, in nonhematopoietic tissues, CD131 expression is likely to be part of a unique profile of related surface receptors, including EPO-R. A characterization of EPO-R expression in various cell types has proven problematic in part due to unspecific epitope binding sites [24] . However, it has been convincingly demonstrated that colocalization of EPO-R/CD131 with vascular endothelial growth factor receptor 2 (VEGF-R2) in CD34+ endothelial progenitor cells is mandatory for a noncalcium-dependent induction of endothelial NO-synthase (eNOS) following the stimulation with vascular endothelial growth factor (VEGF) or EPO [25] . These findings suggest that alternative EPO signaling via EPO-R/CD131 is likely to participate in the activation of various other signaling pathways. Here, we show that an increased CD131 cell surface expression occurs almost instantly in primary mAFBs or mBMSCs following cell stress by heat shock, BHP, or pro-inflammatory activation via LPS and TNFα. Thus, the most plausible mechanism of this CD131 upregulation would be the externalization of preformed receptor units opposed to a more protracted transcriptional upregulation. Conversely, "constitutively activated" mJ774 macrophages showed highest CD131+ cell fractions under nonstress, noninflammatory culture conditions with apparent internalization or shedding in response to LPS-or BHP-induced cell stress. This may be related to a previously described [26] significant co-expression of IL3 and GM-CSF receptors in these cells, as opposed to fibroblastic cell lineages. We conclude that changes in CD131 surface expression appear to be a specific response to cell stress and inflammation that affects the responsiveness to EPO, at least in the selected cell lines.
We also show that ARA290 stimulation following the induction of cell stress decreases apoptosis, mitigates LDH release due to cellular damage, and preserves cytoskeletaldependent cell contractility. ARA290 also abrogated a state of metabolic hyperactivity triggered by LPS and TNFα; this may in turn decrease energy expenditure and preserve resources toward recovery and repair processes. In these experiments, ARA290 was most effective if given within the first hour following the induction of cell stress. Therefore, cytoprotective effects became apparent in a time interval where transcriptional activation of genes was unlikely to play a crucial role in overcoming cellular damage. This understanding concurred with our finding that ARA290 was also able to significantly alter intracellular phosphorylation levels of tyrosine or serine residues as functional groups of various enzymes and regulatory proteins early. At least in mBMSCs, ARA290 showed both synergistic and antagonist effects on LPS-and TNFα-mediated signaling in terms of overall phosphorylation levels.
In addition, we found that another key function of alternative EPO signaling appears to be the modulation of phenotype-dependent secretion profiles. Following cellular damage or pro-inflammatory activation, most cells will not only passively respond to but also actively interact with their environment on a local and systemic level e.g. by secreting various cytokines or chemokines. Concurrent to a previously reported mitigation of inflammatory responses in a burn injury model, we saw that ARA290 treatment suppressed LPS or BHP-induced TNFα secretion in mJ774's macrophages. In fibroblastic phenotypes, mRNA levels of TNFα can also be induced [27] , but this did not translate into a tangible secretion of TNFα in cell lineages used in this study. However, primary mAFBs showed a robust induction of IL6 secretion that was significantly mitigated following the exposure to stressors such as LPS, TNFα, or BHP. In mBMSCs, expression of IL6 was also significantly mitigated by ARA290 stimulation that followed induction with LPS, TNFα, or BHP.
Although EPO-R/CD131 receptor complex-mediated effects related to recovery appeared to be most relevant if ARA290 was given immediately following induced cell stress and/or sublethal cell damage, we also aimed at characterizing a more prolonged modulation of the transcriptome/proteome related to cellular stress responses [28] . By profiling this response in BHP-induced mBMSCs with or without an additional LPS-or TNFα-mediated pro-inflammatory activation, we showed that both components of the EPO-R/CD131 receptor complex are induced, thus likely increasing responsiveness to alternative EPO signaling over time. Stimulation of BMSCs with ARA290 or mrEPO alone did not noticeably affect expression profiles. Conversely, following BHPinduced stress, the effect of ARA290 or mrEPO was a synergistic upregulation of most screened pathway genes. However, the most prominent effects of ARA290 or mrEPO were seen in the context of a co-stimulation with LPS or TNFα. Here, alternative EPO-mediated signaling showed mitigating effects on genes that were strongly upregulated by LPS or TNFα following cell stress induction via BHP, such as FasR, known to mediate pro-apoptotic actions of TNFα or P73, involved in cell cycle control. Overall, mitigating effects on LPS/TNFα-induced transcription were apparent in pathways related to apoptosis, inflammation, and cell cycle control. However, we also saw synergistic effects of ARA290 or mrEPO with LPS/TNFα co-stimulation with gene transcription related to protein stabilization or degradation. Nevertheless, BHP-induced cells remained highly responsive to LPS/ TNFα stimulation which is more likely to be detrimental to cell survival during a phase of recovery from cellular damage such as already demonstrated under conditions of ischemia [29] . In this respect, alternative EPO signaling might act as a functional antagonist of a pro-inflammatory activation of cells, instead channeling cellular resources into repair mechanisms which will promote cell survival. Finally, alternative EPO signaling strongly affected the transcriptional activation of various nuclear promoter sites related to cell stress responses and cell cycle control. However, our evaluation of a possible direct control of alternative EPO signaling on LPS/ TNFα-induced NFκB-mediated transcription remained inconclusive.
One insightful conclusion from our findings is that alternative EPO signaling via the EPO-R/CD131 receptor complex is unlikely to play a significant modulatory role under normal circumstances. This changes dramatically under conditions of cellular stress and a pro-inflammatory environment. However, a distinction has to be made between an isolated induction of cellular damage using e.g. heat shock or BHP-induced oxidative stress vs. solely a stimulation using LPS or TNFα. Regarding the latter, ARA290 overall appears to mostly mitigate a pro-inflammatory activation of responsive cell lines, whereas with isolated cellular damage, ARA290 appears to help maintain a functional cellular apparatus. Both effects result in a net effect of reduced cell death and functional recovery with a return to homeostasis. Since tissue injury in vivo is usually closely related to inflammation and conditions of microbial invasion, we speculate that a potential function of alternative EPO signaling might be to promote cell survival at the expense of other functions. In the context of cellular stress, other investigators have previously proposed that cellular protective heat shock responses and inflammatory pathway activation via interleukin 1 [30] , LPS, and TNFα [31] [32] [33] or activation of NF-kappaB [34] may be mutually exclusive. Thus, our observation of an anti-apoptotic effect along with the blocked increased metabolic activity induced by LPS or TNFα could be intended at diverting intracellular resources into self-repair, as opposed to an energy-consuming activation of proinflammatory pathways. In summary, this study confirms the relevance of cytoprotective actions of alternative EPO signaling as a net effect resulting from modulatory effects both on immediate and delayed cellular stress responses. Our findings support the existence of an innate mechanism to resolve states of cell stress and pro-inflammatory activation.
